Inflammatory cells in node-negative breast cancer

References

• Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, . Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 2008;14:518–27.
   PubMed Web of Science ®Google Scholar
• Dimitriadou V, Koutsilieris M. Mast cell-tumor cell interactions: For or against tumour growth and metastasis? Anticancer Res 1997;17:1541–9.
   PubMed Web of Science ®Google Scholar
• Ranieri G, Ammendola M, Patruno R, Celano G, Zito FA, Montemurro S, . Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients. Int J Oncol 2009;35:115–20.
   PubMed Web of Science ®Google Scholar
• Xiang M, Gu Y, Zhao F, Lu H, Chen S, Yin L. Mast cell tryptase promotes breast cancer migration and invasion. Oncol Report 2010;23:615–9.
   PubMedGoogle Scholar
• Kashiwase Y, Morioka J, Inamura H, Yoshizawa Y, Usui R, Kurosawa M. Quantitative analysis of mast cells in benign and malignant breast lesions. Immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Int Arch Allergy Immunol 2004;134:199–205.
   PubMedGoogle Scholar
• Samoszuk M, Corwin MA. Mast cell inhibitor cromolyn increases blood clotting and hypoxia in murine breast cancer. Int J Cancer 2003;107:159–63.
   PubMedGoogle Scholar
• Amini RM, Aaltonen K, Nevanlinna H, Carvalho R, Salonen L, Heikkila P, . Mast cells and eosinophils in invasive breast carcinoma. BMC Cancer 2007;7:165.
   PubMedGoogle Scholar
• Merlo A, Casalini P, Carcangiu ML, Malventano C, Triulzi T, Menard S, . FOXP3 expression and overall survival in breast cancer. J Clin Oncol 2009;27:1746–52.
   PubMed Web of Science ®Google Scholar
• Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Lee AH, Ellis IO, . An evaluation of the clinical significance of FOXP3(+) infiltrating cells in human breast cancer. Breast Cancer Res Treat 2011;127:99–108.
   PubMed Web of Science ®Google Scholar
• Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, . Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002;169:2756–61.
   PubMed Web of Science ®Google Scholar
• Wolf AM, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck-Loebenstein B. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003;9:606–12.
   PubMed Web of Science ®Google Scholar
• Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: A sample survey for year 1998. Acta Oncol 2009;48:27–33.
   PubMed Web of Science ®Google Scholar
• Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991;19:403–10.
   PubMed Web of Science ®Google Scholar
• Ahlin C, Zhou W, Holmqvist M, Holmberg L, Nilsson C, Jirstrom K, . Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancer. Cancer Epidemiol Biomarkers Prev 2009;18:2501–6.
   PubMed Web of Science ®Google Scholar
• Campbell MJ, Tonlaar NY, Garwood ER, Huo D, Moore DH, Khramtsov AI, . Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome. Breast Cancer Res Treat 2011;128:703–11.
   PubMed Web of Science ®Google Scholar
• Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. J Pathol 2002;196:254–65.
   PubMed Web of Science ®Google Scholar
• Kim DW, Min HS, Lee KH, Kim YJ, Oh DY, Jeon YK, . High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer. Br J Cancer 2008;98:1118–24.
   PubMedGoogle Scholar
• Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Grainge MJ, Lee AH, . Tumor-infiltrating CD8 + lymphocytes predict clinical outcome in breast cancer. J Clin Oncol 2011;29:1949–55.
   PubMed Web of Science ®Google Scholar
• Mahmoud SM, Lee AH, Paish EC, Macmillan RD, Ellis IO, Green AR. The prognostic significance of B lymphocytes in invasive carcinoma of the breast. Breast Cancer Res Treat 2011;127:99–108.
   PubMed Web of Science ®Google Scholar
• Camp RL, Neumeister V, Rimm DL. A decade of tissue microarrays: Progress in the discovery and validation of cancer biomarkers. J Clin Oncol 2008;26:5630–7.
   PubMed Web of Science ®Google Scholar